首页> 外文OA文献 >0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects

【2h】

0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects

机译：0053 SUVN-G3031：有效和选择性组胺H3受体逆激动剂 - 单次和升高剂量的安全性，耐受性和药代动力学，在健康受试者中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ramakrishna Nirogi; Anil Shinde; Koteshwara Mudigonda; Gopinadh Bhyrapuneni; Nageswara Rao Muddana; Raghava Chowdary Palacharla; Devender Reddy Ajjala; Vinod Kumar Goyal; Jyothsna Ravula; Satish Jetta; Abdul Rasheed Mohammed;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects [J] . Nirogi Ramakrishna, Shinde Anil, Mudigonda Koteshwara, Sleep . 2019,第Supplementa1期

机译：0053 SUVN-G3031：有效和选择性的组胺H3受体逆激动剂的安全性，耐受性和药代动力学-健康受试者的单次和多次递增剂量
2. SUVN-G3031, A POTENT AND SELECTIVE HISTAMINE H3 RECEPTOR INVERSE AGONIST: SAFETY, TOLERABILITY AND PHARMACOKINETICS FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY ADULT SUBJECTS [J] . Bhyrapuneni G., Goyal V, Pandey S., Sleep . 2020,第Suppla1期

机译：SUVN-G3031，一种有效和选择性组胺H3受体反向激动剂：在健康成年对象中单一和多个上升剂量后的安全性，耐受性和药代动力学
3. Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses [J] . Clinical drug investigation . 2020,第7期

机译：SUVN-G3031的安全性，耐受性和药代动力学，一种新的组胺-3受体反向激动剂，用于治疗鼻腔梗死，在单一和多剂量剂量之后
4. Pharmacokinetics and Tolerability of Sublingual Fentanyl in Healthy Japanese and Caucasian Volunteers: Phase I, Open-Label Single-Dose Study [C] . U. Lorch, F. Farrell, J. Kilborn, International Pain Clinic Congress . 2008

机译：健康日本和白种人志愿者舌下芬太尼的药代动力学和耐受性：I期，开放标签单剂量研究
5. Safety tolerability pharmacokinetics and pharmacodynamics of PF-06650833 a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor in single and multiple ascending dose randomized phase 1 studies in healthy subjects [O] . Spencer I. Danto, Negin Shojaee, Ravi Shankar P. Singh, 2019

机译：PF-06650833（一种选择性白介素-1受体相关激酶4（IRAK4）抑制剂）在健康受试者的单次和多次递增剂量随机1期研究中的安全性耐受性药代动力学和药效学
6. Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study [O] . Charlotte Bakker, Tim Tasker, Jan Liptrot, 2021

机译：HTL0018318的安全性，药代动力学和探索性亲认知效果，一种选择性M1受体激动剂，健康的年轻成人和老年人：多次上升剂量研究

0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects

著录项

引文网络

相似文献

相关主题

期刊订阅